• 2075 Citations
  • 23 Scopus h-Index
1980 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Gerardo Colon-Otero is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 17 Similar Profiles
Neoplasms Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
African Americans Medicine & Life Sciences
Appointments and Schedules Medicine & Life Sciences
20th Century History Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1980 2019


David, C. S., Jenkins, R. B., Cunningham, J. M., Wettstein, P. J., Buckner, J. C., Lingle, W. L., Kocher, J., Highsmith, W. E. J., Beebe, T. J., Vile, R. G., Okuno, S. H., Sarkaria, J. N., Alberts, S. R., Salisbury, J. L., Van Deursen, J., Diasio, R. B., Sargent, D. J., Thibodeau, S. N., Ingle, J. N., Reid, J. M., Colon-Otero, G., Galanis, E., Weinshilboum, R. M., Jenkins, R. B., Banks, P., Flotte, T., Kwon, E. D., Federspiel, M. J., Pitot, H. C., Dewald, G., Held, K., Liebson, P., Banks, P., Prendergast, F., Weiland, L., Wiebeu, E., Moertel, C., Clapham, D., Burnham, N., O'Connell, M., Spelsburg, T., Maihle, N., Katzmann, J., Wieand, H., Kovach, J., Wold, L., Grendahl, D., McCormick, D., Leibson, P., O'Fallon, J., Ames, M., Kline, B., Prendergast, F., Adjei, A., Chute, C., McKean, D., Highsmith, E., Raghavakaimal, S., Pitot, H., Greipp, P., Wieben, E., Roche, P., Leibson, P., Lawson, M., Grendahl, D., McCormick, D., Ames, M., Wieben, E. D., Flotte, T. J., Adjei, A. & Greipp, P. T.

National Institutes of Health


Project: Research project

Research Personnel

Research Output 1981 2019

  • 2075 Citations
  • 23 Scopus h-Index
  • 73 Article

Constitutively active ESR1 mutations in gynecologic malignancies and clinical response to estrogen-receptor directed therapies

Gaillard, S. L., Andreano, K. J., Gay, L. M., Steiner, M., Jorgensen, M. S., Davidson, B. A., Havrilesky, L. J., Alvarez Secord, A., Valea, F. A., Colon-Otero, G., Zajchowski, D. A., Chang, C. Y., McDonnell, D. P., Berchuck, A. & Elvin, J. A., Jan 1 2019, In : Gynecologic oncology.

Research output: Contribution to journalArticle

Estrogen Receptors
Aromatase Inhibitors

Effects of age and immune landscape on outcome in HER2-positive breast cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) trials

Chumsri, S., Serie, D. J., Li, Z., Pogue-Geile, K. L., Soyano-Muller, A. E., Mashadi-Hossein, A., Warren, S., Lou, Y., Colon-Otero, G., Knutson, K. L., Perez, E. A., Moreno Aspitia, A. & Thompson, E. A., Jan 1 2019, In : Clinical Cancer Research. 25, 14, p. 4422-4430 9 p.

Research output: Contribution to journalArticle

Breast Neoplasms
adjuvant P40
B 31
2 Citations (Scopus)

Single-Arm Phases 1 and 2 Trial of Niraparib in Combination with Pembrolizumab in Patients with Recurrent Platinum-Resistant Ovarian Carcinoma

Konstantinopoulos, P. A., Waggoner, S., Vidal, G. A., Mita, M., Moroney, J. W., Holloway, R., Van Le, L., Sachdev, J. C., Chapman-Davis, E., Colon-Otero, G., Penson, R. T., Matulonis, U. A., Kim, Y. B., Moore, K. N., Swisher, E. M., Färkkilä, A., D'Andrea, A., Stringer-Reasor, E., Wang, J., Buerstatte, N. & 5 others, Arora, S., Graham, J. R., Bobilev, D., Dezube, B. J. & Munster, P., Jan 1 2019, In : JAMA Oncology.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms

CDKN2A germline rare coding variants and risk of pancreatic cancer in minority populations

Mc Williams, R. R., Wieben, E. D., Chaffee, K. G., Antwi, S., Raskin, L., Olopade, O. I., Li, D., Highsmith, W. E. J., Colon-Otero, G., Khanna, L. G., Permuth, J. B., Olson, J. E., Frucht, H., Genkinger, J., Zheng, W., Blot, W. J., Wu, L., Almada, L. L., Fernandez-Zapico, M. E., Sicotte, H. & 2 others, Pedersen, K. S. & Petersen, G. M., Nov 1 2018, In : Cancer Epidemiology Biomarkers and Prevention. 27, 11, p. 1364-1370 7 p.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
African Americans
Odds Ratio
Confidence Intervals
1 Citation (Scopus)

Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer

Norton, N., Fox, N., McCarl, C. A., Tenner, K. S., Ballman, K., Erskine, C. L., Necela, B. M., Northfelt, D. W., Tan, W., Calfa, C., Pegram, M., Colon-Otero, G., Perez, E. A., Clynes, R. & Knutson, K. L., Jun 14 2018, In : Breast Cancer Research. 20, 1, 52.

Research output: Contribution to journalArticle

Breast Neoplasms
Disease-Free Survival